PDL BioPharma, Inc.
PDLIV
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 08/31/2020 | 06/30/2020 | 03/31/2020 | 12/31/2019 | 09/30/2019 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 105.45M | 125.51M | 168.98M | 294.27M |
| Total Receivables | -- | 58.75M | 60.44M | 59.14M | 79.75M |
| Inventory | -- | 12.63M | 10.54M | 8.06M | 20.94M |
| Prepaid Expenses | -- | 29.29M | 22.01M | 7.34M | 11.83M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 289.43M | 332.75M | 70.37M | 100.00K |
| Total Current Assets | -- | 495.55M | 551.26M | 313.90M | 406.89M |
|
|
|||||
| Total Current Assets | -- | 495.55M | 551.26M | 313.90M | 406.89M |
| Net Property, Plant & Equipment | -- | 3.04M | 3.26M | 3.92M | 8.02M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 12.55M | 12.88M | 13.19M | 361.29M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 4.09M | 9.77M | 283.19M | 4.23M |
| Total Assets | -- | 520.66M | 659.80M | 717.21M | 865.15M |
|
|
|||||
| Total Accounts Payable | -- | 3.52M | 5.23M | 2.68M | 13.26M |
| Total Accrued Expenses | -- | 12.67M | 10.10M | 10.20M | 17.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 760.00K | 723.00K |
| Total Finance Division Other Current Liabilities | -- | 20.04M | 26.42M | 32.05M | 9.09M |
| Total Other Current Liabilities | -- | 20.04M | 26.42M | 32.05M | 9.09M |
| Total Current Liabilities | -- | 36.24M | 41.74M | 45.69M | 40.93M |
|
|
|||||
| Total Current Liabilities | -- | 36.24M | 41.74M | 45.69M | 40.93M |
| Long-Term Debt | -- | 13.51M | 13.30M | 27.25M | 132.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 634.00K | 751.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 50.91M | 51.64M | 50.35M | 53.55M |
| Total Liabilities | -- | 100.66M | 106.69M | 123.93M | 227.71M |
|
|
|||||
| Common Stock & APIC | -- | 1.14M | 1.21M | 1.24M | 1.14M |
| Retained Earnings | -- | 485.49M | 621.13M | 670.83M | 736.70M |
| Treasury Stock & Other | -- | -66.16M | -69.11M | -78.88M | -100.42M |
| Total Common Equity | -- | 420.47M | 553.23M | 593.20M | 637.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -- | 420.47M | 553.23M | 593.20M | 637.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -467.00K | -110.00K | 78.00K | 16.00K |
| Total Equity | -- | 420.00M | 553.12M | 593.28M | 637.43M |
|
|
|||||